Antimicrobial resistance, genotypic characterization and pulsed-field gel electrophoresis typing of extended spectrum β-lactamases-producing clinical Escherichia coli strains in Macao, China

Chinese Medical Journal

Volumn 124, Issue 17, 2011, Pages 2701-2707

  Ye, Qian Hong ^a   Lau, Ying ^a   Liang, Bin ^b   Tian, Su Fei ^b  

^a MACAO POLYTECHNIC INSTITUTE   (Macao)

^b CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Antimicrobial resistance; Escherichia coli; Extended spectrum lactamases; Macao; Pulsed field gel electrophoresis

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AZTREONAM; BETA LACTAMASE CTX M; BETA LACTAMASE CTX M 1; BETA LACTAMASE CTX M 14; BETA LACTAMASE CTX M 2; BETA LACTAMASE CTX M 8; BETA LACTAMASE CTX M 9; BETA LACTAMASE SHV; BETA LACTAMASE TEM 1; CEFAZOLIN; CEFOTAXIME; CEFPODOXIME; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; IMIPENEM; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; SULFAMETHOXAZOLE; TETRACYCLINE; TRIMETHOPRIM; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CONTROLLED STUDY; DISK DIFFUSION; DNA SEQUENCE; ESCHERICHIA COLI; GENE AMPLIFICATION; GENOTYPE; ISOELECTRIC FOCUSING; KLEBSIELLA PNEUMONIAE; MACAO; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; POLYMERASE CHAIN REACTION; PULSED FIELD GEL ELECTROPHORESIS;

EID: 80052548308     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2011.17.025     Document Type: Article

References (27)

1. Wang H, Chen M, Ni Y, Liu Y, Sun H, Yu Y, et al. Antimicrobial resistance among clinical isolates from the Chinese Meropenem Surveillance Study (CMSS), 2003-2008. Int J Antimicrob Agents 2010; 35:227-234.
2. PM. Prevalence and clonality of extended-spectrum ß-lactamases in Asia. Clin Microbiol Infect 2008; 14 Suppl 1: 159-165.
3. Vogelaers D, De Bels D, Foret F, Cran S, Gilbert E, Schoonheydt K, et al. Patterns of antimicrobial therapy in severe nosocomial infections: empiric choices, proportion of appropriate therapy, and adaptation rates-a multicentre, observational survey in critically ill patients. Int J Antimicrob Agents 2010; 35: 375-381.
4. Rodriguez-Bano J, Pascual A. Clinical significance of extended-spectrum beta-lactamases. Exp Rev Antiinfective Ther 2008; 6: 671-683.
5. Pitout JD, Laupland KB. Extended-spectrum ß-lactamases-producting Enterobacteriaceae: an emerging public concern. Lancet Infect Dis 2008; 8: 159-166.
6. Tan TY, Ng LS, He J, Hsu LY. CTX-M and ampC beta-lactamases contributing to increased prevalence of ceftriaxone-resistant Escherichia coli in Changi General Hospital, Singapore. Diagnostic Microb Infect Dis 2009; 66: 210-213.
7. Yu WL, Chuang YC, Walther-Rasmussen J. Extendedspectrum beta-lactamasses in Taiwan: epemiology, detection, treatment and infection control. J Microbiol Immunol Infect 2006; 39: 264-277.
8. Paterson DI, Bonomo RA. Extended-spectrum ß-lactamases: a clinical updated. Clin Microbiol Rev 2005; 18: 657-686.
9. Macau Government Tourist Office. About Macau. 2009 (Accessed April 23, 2009 at http://www.macutourism.gov.mo/en/info/inf.php).
10. Laupland KB, Church DL, Vidakovich J, Mucenski M, Pitout JDD. Community-onset extended-spectrum ß-lactamase (ESBL) producing Escherichia coli: importance of international travel. Br Infect Soc 2008; 57: 441-448.
11. Pitout JD, Campbell L, Church DL, Gregson DB, Laupland KB. Molecular characteristics of travel-related extendedspectrum- beta-lactamase-producing Escherichia coli isolates from the Calgary Health Region. Antimicrob Agents Chemother 2009; 53: 2539-2543.
12. Macau Health Center. Health indicator and primary care in Macau. Macau: Services of Health Centers; 2004.
13. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: seventeenth informational supplement (M100-S18). Wayne, PA: CLSI; 2008.
14. Wang PY, Liu YC, Zhao M, Sun LY, Luo WY, Gao HQ, et al. Genotypes of extended-spetrum ß-lactamases produced by antibiotic-resistant Escherichia coli and Klebsiella pneumoniae in surgical intensive care unit. J Peking Univ (Health Sci) 2004; 36: 637-641.
15. Eckert C, Gautier V, Arlet G. DNA sequence analysis of the genetic environment of various blaCTX-M genes. J Antimicrob Chemother 2006; 57: 14-23.
16. Bardford P. Extended-spetrum ß-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 2001; 14: 933-951.
17. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995; 33: 2233-2239.
18. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: seventeenth informational supplement (M100-S17). Wayne, PA: CLSI; 2007.
19. Tenover FC, Emery SL, Spiegel CA, Bradford PA, Eells S, Endimiani A, et al. Identification of plasmid-mediated AmpC beta-lactamases in Escherichia coli, Klebsiella spp., and proteus species can potentially improve reporting of cephalosporin susceptibility testing results. J Clin Microbiol 2009; 47: 294-299.
20. Ho PL, Poon WW, Loke SL, Leung MS, Chow KH, Wong RC, et al. Community emergence of CTX-M type extendedspectrum beta-lactamases among urinary Escherichia coli from women. J Antimicrob Chemother 2007; 60: 140-144.
21. Chanawong A, M'Zali FH, Heritage J, Xiong JH, Hawkey PM. Three cefotaximases, CTX-M-9, CTX-M-13, and CTX-M-14, among enterobacteriaceae in the People's Republic of China. Antimicrob Agents Chemother 2002; 46: 630-637.
22. Rossolini GM, D'Andrea MM, Mugnaioli C. The spread of CTX-M-types extended-spetrum ß-lactamases. Clin Microbiol Infect 2008; 14 Suppl 1: 33-41.
23. Wu LT, Wu HJ, Chung JG, Chuang YC, Cheng KC, Yu WL. Dissemination of Proteus mirabilis isolates harboring CTX-M-14 and CTX-M-3 ß-lactamases at 2 hospitals in Taiwan. Diagnostic Microb Infect Dis 2006; 54: 89-94.
24. K. Extended-spetrum ß-lactamases in NOrth America, 1987-2006. Clin Microbiol Infect 2008; 14 Suppl 1: 134-143.
25. Canton R, Novais A, Valverde A, Machado E, Peixe L, Baquero F, et al. Prevalence and spread of extended-spectrum ß-lactamases-producing Enterobacteriaceae in Europe. Clin Microbiol Infect 2008; 14 Suppl 1: 144-153.
26. Bonnet R. Growing group of extended-spectrum beta-lactamases: the CTX-M enzymes. Antimicrob Agents Chemother 2004; 48: 1-14.
27. Peirano G, Pitout JD. Molecular epidemiology of Escherichia coli producing CTX-M ß-lactamases: the worldwide emergence of clone ST131 O25:H4. Int J Antimicrob Agents 2010; 35: 316-321.